🇺🇸 FDA
Pipeline program

FT536

2024LS061

Phase 1 mab active

Quick answer

FT536 for Astrocytoma is a Phase 1 program (mab) at FATE THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
FATE THERAPEUTICS INC
Indication
Astrocytoma
Phase
Phase 1
Modality
mab
Status
active

Clinical trials